PMTW PennyMac posts 197 percent Q4 2025 EPS beat with shares edging higher following the earnings release Illumina Inc ILMN DRAGEN v45 Launch Expands Genomic Workflow Capabilities Positions Firm for Accelerated Recurring Revenue Growth SYRE Spyre Therapeutics reports narrower Q4 2025 pershare loss than consensus forecasts with shares edging higher in todays trading Consumer Discretionary Select Sector SPDR Fund XLY Gains Amid Broad Market Rally Earnings and Commodity Tailwinds